The HIRA decided to reorganize the Drug Reimbursement Evaluation Committee due to the Xalkori’s lobbying incident

The Health Insurance Review & Assessment Service (HIRA), embarrassed by the Xalkori’s lobbying incident, decided to reorganize the Drug Reimbursement Evaluation Committee (DREC).

The purpose of the reorganization is to newly create its report system to oppose unfair requests and open the list of its members.

The HIRA preannounced the ‘Partial Amendment for Operational Regulation of the Drug R...